Elevated plasma levels of lipoprotein(a) in psychiatric patients: A possible contribution to increased vascular risk

European Psychiatry

Volumn 21, Issue 2, 2006, Pages 129-133

  Emanuele, Enzo ^a   Carlin, Maria V ^a   D'Angelo, Angela ^a   Peros, Emmanouil ^a   Barale, Francesco ^a   Geroldi, Diego ^a   Politi, Pierluigi ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Bipolar disorder; Cardiovascular risk; Lipoprotein(a); Major depression; Schizophrenia

Indexed keywords

LIPOPROTEIN A;

ADULT; ARTICLE; BIPOLAR DISORDER; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA;

ADULT; AGED; BIPOLAR DISORDER; BODY MASS INDEX; CORONARY ARTERIOSCLEROSIS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 33644642029     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.10.002     Document Type: Article

References (34)

1. J.J. Albers, S.M. Marcovina, and M.S. Lodge The unique lipoprotein(a): properties and immunochemical measurement Clin. Chem. 36 1990 2019 2026
2. R. Anda, D. Williamson, D. Jones, C. Macera, E. Eaker, and A. Glassman Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults Epidemiology 4 1993 285 294
3. M. Bihari-Varga, E. Gruber, M. Rotheneder, R. Zechner, and G.M. Kostner Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta Arteriosclerosis 8 1988 851 857
4. F. Cassidy, and B.J. Carroll Vascular risk factors in late onset mania Psychol. Med. 32 2002 359 362
5. P. Cremer, D. Nagel, B. Labrot, H. Mann, R. Muche, and H. Elster Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk, Incidence and Prevalence Study (GRIPS) Eur. J. Clin. Invest. 24 1994 444 453
6. P.N. Hopkins, L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, and R.R. Williams Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease Arterioscler. Thromb. Vasc. Biol. 17 1997 2783 2792
7. D.F. Horrobin, and C.N. Bennett Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes Prostaglandins Leukotrienses Essent Fatty Acids 60 1999 217 234
8. A. Imhof, D. Rothenbacher, N. Khuseyinova, A. Hoffmeister, W. Maerz, and M. Nauck Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease J. Cardiovasc. Risk 10 2003 362 370
9. K.E. Joynt, D.J. Whellan, and C.M. O'Connor Depression and cardiovascular disease: mechanisms of interaction Biol. Psychiatry 54 2003 248 261
10. S. Kojima, P.C. Harpel, and D.B. Rifkin Lipoprotein(a) inhibits the generation of transforming growth factor β: an endogenous inhibitor of smooth muscle cell migration J. Cell Biol. 113 1991 1439 1445
11. G.M. Kostner, P. Avogaro, G. Cazzolato, E. Marth, G. Bittolo-Bon, and G.B. Quinci Lipoprotein Lp(a) and the risk for myocardial infarction Atherosclerosis 38 1987 51 61
12. G. Lippi, and G. Guidi Lipoprotein(a): an emerging cardiovascular risk factor Crit. Rev. Clin. Lab. Sci. 40 2003 1 42
13. M. Maes Evidence for an immune response in major depression: a review and hypothesis Prog. Neuropsychopharmacol. Biol. Psychiatry 19 1995 11 38
14. M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. DeJonckheere, and J. Raus Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1b and soluble interleukin-2 receptor production Acta Psychiatr. Scand. 84 1991 379 386
15. M. Maes, M. Van der Planken, A. Van Gastel, and R. Desnyder Blood coagulation and platelet aggregation in major depression J. Affect. Disord. 40 1996 35 40
16. R.G. McCreadie Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study Br. J. Psychiatry 183 2003 534 539
17. J. McKenney Niacin for dyslipidemia: considerations in product selection Am. J. Health Syst. Pharm. 60 2003 995 1005
18. E. Messamore, W.F. Hoffman, and A. Janowsky The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study Schizophr. Res. 62 2003 251 258
19. H.J. Milionis, V. Mittari, G. Exarchakos, R. Kalaitzidis, A.T. Skevas, and M.S. Elisaf Lipoprotein(a) and acute-phase response in patients with vestibular neuronitis Eur. J. Clin. Invest. 33 2003 1045 1050
20. H.J. Milionis, Z. Efstathiadou, A.D. Tselepis, E.T. Bairaktari, L.D. Tsironis, and A. Tsatsoulis Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine Thyroid 13 2003 365 369
21. K. Miwa, K. Nakagawa, N. Yoshida, Y. Taguchi, and H. Inoue Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm J. Am. Coll. Cardiol. 35 2000 1200 1205
22. D.L. Musselman, D.L. Evans, and C.B. Nemeroff The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment Arch. Gen. Psychiatry 55 1998 580 592
23. C.M. O'connor, P.A. Gurbel, and V.L. Serebruany Depression and ischemic heart disease Am. Heart J. 140 2000 63 69
24. T.M. Palabrica, A.C. Liu, M.J. Aronovitz, B. Furie, R.M. Lawn, and B.C. Furie Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis Nat Med 1995 256 259
25. P.M. Plotsky, M.J. Owens, and C.B. Nemeroff Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis Psychiatr. Clin. North Am. 21 1998 293 307
26. P. Politi, M. Piccinelli, C. Klersy, S. Madini, L.G. Segagni, and C. Fratti Mortality in psychiatric patients 5-21:years after hospital admission in Italy Psychol. Med. 32 2002 227 237
27. R. Ramharack, M.A. Spahr, J.S. Kreick, and C.S. Sekerke Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues J. Lipid Res. 37 1996 2029 2040
28. G.G. Rhoads, G. Dahlen, K. Berg, N.E. Morton, and A.L. Dannenberg Lp(a) lipoprotein as a risk factor for myocardial infarction JAMA 256 1986 2540 2544
29. D. Rouy, P. Grailhe, F. Nigon, J. Chapman, and E. Angles-Cano Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator: in vitro studies in a plasma milieu Arterioscler. Thromb. 11 1991 629 638
30. A.M. Scanu, and J. Hinman Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels Lipids 37 2002 439 444
31. E.J. Schaefer, S. Lamon-Fava, J.L. Jenner, J.R. McNamara, J.M. Ordovas, and C.E. Davis Lipoprotein(a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial JAMA 271 1994 999 1003
32. H. Tavares, J. Yacubian, L.L. Talib, N.R. Barbosa, and W.F. Gattaz Increased phospholipase A2 activity in schizophrenia with absent response to niacin Schizophr. Res. 61 2003 1 6
33. W. Terres, E. Tatsis, B. Pfalzer, F.U. Beil, U. Beisiegel, and C.W. Hamm Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) Circulation 91 1995 948 950
34. G. Utermann, H.G. Kraft, H.J. Menzel, T. Hopferwieser, and C. Seitz Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of LP(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma Hum. Genet. 78 1988 41 46